Literature DB >> 15732227

Lung cancer audit in an Irish teaching hospital.

P M Logan1.   

Abstract

BACKGROUND: Lung cancer is the most common cause of cancer-related death in Ireland. There are few complete data sets available as to the stage and cell type of lung cancers at time of presentation in Ireland. AIM: To audit the lung cancers presenting to a large Dublin teaching hospital over a 12-month period.
METHOD: Prospective evaluation of all lung tumours presenting to our institution over a consecutive 12-month period.
RESULTS: One hundred and ninety-eight lung cancers presented over the study period. There were 34 cases of small cell carcinoma and 150 cases of non-small cell carcinoma (NSCC). Fourteen patients were too ill or compromised at time of presentation for tissue confirmation. The most common cell type was squamous carcinoma. Eighty-four per cent of the NSCCs were either stage 3 or 4 at presentation.
CONCLUSION: Most lung cancers present late in the time course of the disease. Distribution of cell type and location are similar in Ireland and other developed countries.

Entities:  

Mesh:

Year:  2004        PMID: 15732227     DOI: 10.1007/bf02914514

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  2 in total

1.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

2.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Authors:  R M Pieterman; J W van Putten; J J Meuzelaar; E L Mooyaart; W Vaalburg; G H Koëter; V Fidler; J Pruim; H J Groen
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

  2 in total
  2 in total

1.  Screening for lung cancer using low dose CT scanning: results of 2 year follow up.

Authors:  R MacRedmond; G McVey; M Lee; R W Costello; D Kenny; C Foley; P M Logan
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

2.  Lung cancer in Ireland.

Authors:  F O'Connell
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.